P-36 Prevalence of Co-Infection of Human Immunodeficiency Virus and Hepatitis B and Hepatitis C

Abstract

The human immunodeficiency virus (HIV) remains a major global public health problem, and about a third of those infected with HIV are co-infected with hepatotropic viruses. This study endeavors to raise awareness, find better methods, and design public health policies to address the diseases in more effective ways. The country of focus is Madagascar because it is considered a highly endemic area for hepatitis B (HBC) with the prevalence of it shown as 23% in the general population. The goal is to determine the prevalence of co-infection with HIV and HBC and hepatitis C (HCV) in five hospitals.

Acknowledgments

Andrews University Faculty Research Grant (Joel Raveloharimisy).

AU Office of Research & Creative Scholarship.

Start Date

3-2-2018 2:30 PM

This document is currently not available here.

Share

COinS
 
Mar 2nd, 2:30 PM

P-36 Prevalence of Co-Infection of Human Immunodeficiency Virus and Hepatitis B and Hepatitis C

The human immunodeficiency virus (HIV) remains a major global public health problem, and about a third of those infected with HIV are co-infected with hepatotropic viruses. This study endeavors to raise awareness, find better methods, and design public health policies to address the diseases in more effective ways. The country of focus is Madagascar because it is considered a highly endemic area for hepatitis B (HBC) with the prevalence of it shown as 23% in the general population. The goal is to determine the prevalence of co-infection with HIV and HBC and hepatitis C (HCV) in five hospitals.